Evidence map›Paper›PMID 26206488›Full record

ArticleMolecular pharmacology2015

Adenylyl Cyclase 5 Regulation by Gβγ Involves Isoform-Specific Use of Multiple Interaction Sites.

Cameron S Brand, Rachna Sadana, Sundeep Malik, Alan V Smrcka, Carmen W Dessauer

Open access · bronzeAbstract read
In one paragraph

Article in Molecular pharmacology, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 21 papers.

0numbers the graph read from it
0cells of the map it votes in
21citing papers in PubMed
0.8field-weighted citation impact, top 28% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

21 citing papers in PubMed, 46 citations in OpenAlex.

  1. Article
  2. Review
  3. Article
  4. Article
  5. Article
  6. Article
  7. Review
  8. Article
  9. Review
  10. Article
  11. Article
  12. Review
  13. Review
  14. Review
  15. Article
  16. Article
  17. Pharmacological modulation of the COPharmacology & therapeutics · 2018
    Review
  18. Function of Adenylyl Cyclase in Heart: the AKAP Connection.Journal of cardiovascular development and disease · 2018
    Review
  19. Article
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 3 institutions in 1 country.

Cameron S BrandDepartment of Integrative Biology and Pharmacology, University of Texas Health Science Center, Houston, Texas (C.S.B., C.W.D.); Department of Natural Sciences, University of Houston-Downtown, Houston, Texas (R.S.); and Department of Pharmacology and Physiology, University of Rochester School of Medicine, Rochester, New York (S.M., A.V.S.).
Rachna SadanaDepartment of Integrative Biology and Pharmacology, University of Texas Health Science Center, Houston, Texas (C.S.B., C.W.D.); Department of Natural Sciences, University of Houston-Downtown, Houston, Texas (R.S.); and Department of Pharmacology and Physiology, University of Rochester School of Medicine, Rochester, New York (S.M., A.V.S.).
Sundeep MalikDepartment of Integrative Biology and Pharmacology, University of Texas Health Science Center, Houston, Texas (C.S.B., C.W.D.); Department of Natural Sciences, University of Houston-Downtown, Houston, Texas (R.S.); and Department of Pharmacology and Physiology, University of Rochester School of Medicine, Rochester, New York (S.M., A.V.S.).
Alan V SmrckaDepartment of Integrative Biology and Pharmacology, University of Texas Health Science Center, Houston, Texas (C.S.B., C.W.D.); Department of Natural Sciences, University of Houston-Downtown, Houston, Texas (R.S.); and Department of Pharmacology and Physiology, University of Rochester School of Medicine, Rochester, New York (S.M., A.V.S.).
Carmen W DessauerDepartment of Integrative Biology and Pharmacology, University of Texas Health Science Center, Houston, Texas (C.S.B., C.W.D.); Department of Natural Sciences, University of Houston-Downtown, Houston, Texas (R.S.); and Department of Pharmacology and Physiology, University of Rochester School of Medicine, Rochester, New York (S.M., A.V.S.) Carmen.W.Dessauer@uth.tmc.edu.
The University of Texas Health Science Center at Houston · USUniversity of Houston - Downtown · USUniversity of Rochester · US

Funding

REGULATION OF ADENYLYL CYCLASE SIGNALING PATHWAYSR01GM060419 · NIGMS · UNIVERSITY OF TEXAS HLTH SCI CTR HOUSTON · PI DESSAUER, CARMEN W. · 2000 to 2021
$6.9M
Selective Targeting of G Protein beta gamma Subunits with Small MoleculesR01GM081772 · NIGMS · UNIVERSITY OF ROCHESTER · PI SMRCKA, ALAN V. · 2008 to 2017
$3.2M
NIGMS NIH HHS R01 GM060419NIGMS NIH HHS R01 GM081772NIGMS NIH HHS R01-GM60419NIGMS NIH HHS R01-GM81772
6 · The paper itself

Abstract

Adenylyl cyclase (AC) converts ATP into cyclic AMP (cAMP), an important second messenger in cell signaling. Heterotrimeric G proteins and other regulators are important for control of AC activity. Depending on the AC isoform, Gβγ subunits can either conditionally stimulate or inhibit cAMP synthesis. We previously showed that the Gαs-βγ heterotrimer binds to the N terminus (NT) of type 5 AC (AC5). We now show that Gβγ binds to the NT of a wide variety of AC isoforms. We hypothesized that Gβγ/AC5 interactions involving inactive heterotrimer and Gβγ stimulation of AC5 were separable events. Mutations of the Gβγ "hotspot" show that this site is necessary for AC5 stimulation but not for interactions with the first 198 aa of AC5NT, which is a G protein scaffolding site. This contrasts with AC6, where the Gβγ hotspot is required for both interactions with AC6NT and for stimulation of AC6. Additionally, the SIGK hotspot peptide disrupts Gβγ regulation of AC isoforms 1, 2, and 6, but not AC5. Gβγ also binds the C1/C2 catalytic domains of AC5 and AC6. Finally, cellular interactions with full-length AC5 depend on multiple sites on Gβγ. This suggests an isoform-specific mechanism in which bound Gβγ at the AC5NT is ideally situated for spatiotemporal control of AC5. We propose Gβγ regulation of AC involves multiple binding events, and the role of the AC NT for mechanisms of regulation by heterotrimeric G protein subunits is isoform-specific.

Indexed as

Adenylyl CyclasesBinding SitesGTP-Binding Protein beta SubunitsGTP-Binding Protein gamma SubunitsHEK293 CellsHumansProtein IsoformsProtein Structure, SecondaryAdenylyl Cyclasesadenylyl cyclase type VG-protein Beta gammaGTP-Binding Protein beta SubunitsGTP-Binding Protein gamma SubunitsProtein Isoforms

Identifiers

PMID26206488
PMCPMC4576683
OpenAlexW2135249891

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.